Vitality Women
Natural health product licensed in Canada
- Licence holder
- Melaleuca, Inc.
- NPN or DIN-HM
- 80031416
- Status
- Active licence
- Licence date
- 13 April 2012
- Revision date
- 13 April 2021
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 10 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Cuivre: up to 3,000 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2,000 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Sélénium: up to 105 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 50 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Chrome: up to 120 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 25 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine E Source : D-alpha-tocophéryl succinate Potency : 15 UI | 10 mg AT | Not calculated |
| Calcium Source : Chlorure de calcium | 125 mg | 250,000 µg |
| Calcium Source : Carbonate de calcium | 125 mg | 250,000 µg |
| Calcium Source : Gluconate de calcium | 125 mg | 250,000 µg |
| Calcium Source : Citrate de calcium | 125 mg | 250,000 µg |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 5 mg | 10,000 µg |
| Vitamine K1 Source : Phytonadione | 14 mcg | 28 µg |
| Folate Source : Acide folique | 400 mcg | Not calculated |
| Cuivre Source : Sulfate de cuivre (II) | 1.5 mg | 3,000 µg |
| Riboflavine Source : Riboflavine | 8.5 mg | 17,000 µg |
| Sélénium Source : Sélénite de sodium | 52.5 mcg | 105 µg |
| Fer Source : Sulfate ferreux | 4.5 mg | 9,000 µg |
| Manganèse Source : Sulfate de manganèse | 1.25 mg | 2,500 µg |
| Zinc Source : Sulfate de zinc | 7.5 mg | 15,000 µg |
| Chrome Source : Chlorure chromique hexahydraté | 60 mcg | 120 µg |
Non-medicinal ingredients
phosphate de dicalcium, Carnuba wax, Acide L-aspartique, Poly(éthylène glycol), Stéarate de magnésium, Dioxyde de silicium, Eau, Glycine, Saveur de vanille naturelle, Hydroxypropylcellulose, Gum acacia, Acide stéarique, Citrate de potassium, Cellulose gum, Inuline, Hydroxyde de sodium, Maltodextrine, Microcrystalline cellulose, Hydroxypropyl methylcellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
A factor in the maintenance of good health. Calcium intake, when combined with sufficient vitamin D, a healthy diet and regular exercise, may reduce the risk of developing osteoporosis. Helps the body to metabolize carbohydrates, fats and proteins. Provides antioxidants for the manitenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80031416
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging